ozempic retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide 2026: 28.7% Weight Loss

GLP-1 shot tracker reminders: Ozempic, Mounjaro, Wegovy, Zepbound, Compound GLP1

From "Ozempic face" and dry skin to acne and hair loss, GLP-1 medications can bring unexpected changes to your skin, hair and overall appearance

To stay ahead of this shifting environment, pharma companies should consider the following imperatives: Massive patient drop-off undermines obesity GLP-1 uptake: Despite strong demand, only 10% of obesity patients persist with therapy after one year

Hands-on certification from Empire Medical Training.

Unlock your bodys full potential with Retatrutide, the next-generation peptide designed to support weight management, appetite control, and metabolic health